Celtaxsys is a pharmaceutical company developing treatments for patients with rare inflammatory diseases including cystic fibrosis. It provides an investigational medicine, acebilustat, as a once-daily, oral therapy for the treatment of lung inflammation associated with cystic fibrosis that has the potential of doing so without immune suppression.
|HQ||Atlanta, GA, US||Map|
|Employees (est.) (Jul 2020)||6|
Celtaxsys total Funding
Celtaxsys latest funding size
Time since last funding
|6 years ago|
|Domain Associates, GRA Venture Fund, RMI Partners, Lumira Ventures, Masters Capital Management|
Celtaxsys has 96 Twitter Followers. The number of followers has increased 0.8% month over month and increased 1.1% quarter over quarter
When was Celtaxsys founded?
Celtaxsys was founded in 2004.
How many employees does Celtaxsys have?
Celtaxsys has 6 employees.
Who are Celtaxsys competitors?
Competitors of Celtaxsys include MyoKardia, Ironwood Pharmaceuticals and Athersys.
Where is Celtaxsys headquarters?
Celtaxsys headquarters is located at 201 17th St NW #530, Atlanta.
Where are Celtaxsys offices?
Celtaxsys has offices in Atlanta and Brisbane City.
How many offices does Celtaxsys have?
Celtaxsys has 2 offices.
Receive alerts for 300+ data fields across thousands of companies